Potassium Ion

Potassium Ion

SCHEMBL29254100

COB([O-])ON1CCCC(C)C1.[K+]

nearest known ligand 0.30

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL771653 0.73
SCHEMBL28900167 0.64 ALDH1A1 (0.38) ALDH1A1LMNAPOLB
SCHEMBL32681711 0.64 KDM4E (0.40) ALDH1A1LMNAPOLB
SCHEMBL7234663 0.62 ALDH1A1 (0.43) ALDH1A1LMNAPOLB
SCHEMBL31035868 0.62 KDM4E (0.43) ALDH1A1LMNAPOLB
SCHEMBL11809950 0.61 ALDH1A1 (0.39) ALDH1A1LMNAPOLB
SCHEMBL15720375 0.60 ALDH1A1 (0.31) ALDH1A1LMNA
SCHEMBL15720476 0.60 ALDH1A1 (0.31) ALDH1A1LMNA
Potassium Ion SCHEMBL29102526 0.60
SCHEMBL81240 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118139856-A Parallel-ring compounds as Cbl-b inhibitors 海南先声再明医药股份有限公司 2024-06-04 CN disclosed
CN-117940404-A Tricyclic compounds as Cbl-b inhibitors 海南先声再明医药股份有限公司 2024-04-26 CN disclosed